The purpose of this Funding Opportunity Announcement (FOA) is to encourage grant applications that address the long term goal and objective of developing sustained release strategies for HIV treatment or prevention.
NIH/NIMH 2 P01 DA028555; Howard Gendelman (PI); 07/01/15 – 06/30/20
NIH/NIAID R01 AI114405; Caren Freel-Meyers (PI); 07/15/14 – 06/30/18
NIH/NIAID UM1 AI120176; Rodney Ho, PI; 08/01/2015 – 07/31/20
The Bill & Melinda Gates Foundation and its funding partners in the Grand Challenges family of grant programs are inviting innovators to apply for grant opportunities. Here find one that may be of interest to LEAP investigators.
The Gates Foundation invests in areas that advance the development and delivery of new HIV prevention methods while improving the efficiency and effectiveness of existing prevention and treatment efforts.